Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent injections. A new FDA approval brings acromegaly patients the choice of a once-daily pill that ...

PANTHERx® Rare has been chosen by Chiesi as the exclusive specialty pharmacy to distribute MYCAPSSA® (octreotide). The ...

Sept 25 (Reuters) - The U.S. Food and Drug Administration approved Crinetics Pharmaceuticals' (CRNX.O), opens new tab drug to treat a rare hormonal disorder on Thursday, making it the first once-daily ...

(RTTNews) - Crinetics Pharmaceuticals Inc. (CRNX) is approaching a watershed moment in its corporate and clinical trajectory. On September 25, 2025, the FDA is expected to announce its decision on the ...